Dr George Harb
VP of Regenerative Biology at Cellino
XEGENGeorge Harb is Vice President of Regenerative Biology at Cellino Biotech, an iPSC platform company located in Cambridge, MA.
He has experience in pluripotent stem cell-based therapies. Most recently as Sr. Director at Vertex Pharmaceuticals, where he led stem cell and islet research programs
From 2015 to 2021 George led cell therapy R&D at Semma Therapeutics and later Vertex Pharmaceuticals following the acquisition of Semma in 2019. Semma was founded in 2015 to develop stem cell derived islet cell replacement therapies for Type 1 diabetes. Prior to joining Semma, George was at the Novartis Institute for Biomedical Research in San Diego, CA developing small molecule inducers of human beta cell proliferation and survival.
